Cargando…
RE: Praluent (Alirocumab)-Induced Renal Injury
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844452/ https://www.ncbi.nlm.nih.gov/pubmed/28974137 http://dx.doi.org/10.1177/0897190017734429 |
| _version_ | 1783305243606384640 |
|---|---|
| author | Rosenson, Robert S. Larrey, Dominique Waters, David D. Olsson, Anders G. |
| author_facet | Rosenson, Robert S. Larrey, Dominique Waters, David D. Olsson, Anders G. |
| author_sort | Rosenson, Robert S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5844452 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-58444522018-03-20 RE: Praluent (Alirocumab)-Induced Renal Injury Rosenson, Robert S. Larrey, Dominique Waters, David D. Olsson, Anders G. J Pharm Pract Letter to the Editor SAGE Publications 2017-10-03 2018-04 /pmc/articles/PMC5844452/ /pubmed/28974137 http://dx.doi.org/10.1177/0897190017734429 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution 4.0 License (http://www.creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Letter to the Editor Rosenson, Robert S. Larrey, Dominique Waters, David D. Olsson, Anders G. RE: Praluent (Alirocumab)-Induced Renal Injury |
| title | RE: Praluent (Alirocumab)-Induced Renal Injury |
| title_full | RE: Praluent (Alirocumab)-Induced Renal Injury |
| title_fullStr | RE: Praluent (Alirocumab)-Induced Renal Injury |
| title_full_unstemmed | RE: Praluent (Alirocumab)-Induced Renal Injury |
| title_short | RE: Praluent (Alirocumab)-Induced Renal Injury |
| title_sort | re: praluent (alirocumab)-induced renal injury |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844452/ https://www.ncbi.nlm.nih.gov/pubmed/28974137 http://dx.doi.org/10.1177/0897190017734429 |
| work_keys_str_mv | AT rosensonroberts repraluentalirocumabinducedrenalinjury AT larreydominique repraluentalirocumabinducedrenalinjury AT watersdavidd repraluentalirocumabinducedrenalinjury AT olssonandersg repraluentalirocumabinducedrenalinjury AT repraluentalirocumabinducedrenalinjury |